About Hepatocellular Carcinoma Stage B
Hepatocellular carcinoma (HCC) is a tumor that develops in the liver. The stage of liver cancer indicates the severity of the cancer and may help guide treatment. One common staging system is the Barcelona Clinic Liver Cancer (BCLC) criteria, which considers the whether the cancer has spread, how well the liver is working, the general health and wellness of the patient, and symptoms caused by the cancer.
Stage B HCC is considered intermediate-stage HCC. Stage B HCC is characterized by:
- Extensive multifocal disease without vascular invasion.
- Preserved liver function.
- Absence of cancer-related symptoms.
- Tumor sizes larger than 3cm to over 10cm) and numbers (2 to over 20)
- Good liver function (Child-Pugh classes A or B)
The prognosis of patients with Stage B HCC can vary. Treatment decisions should be individualized based on factors such as overall health, tumor characteristics, and patient preferences.
HCC is caused genetic changes in DNA can be inherited from parents or acquired due to irregularities during cell division.
Non-modifiable risk factors (factors a person cannot change or control) for HCC include:
- History of primary sclerosing cholangitis and inflammatory bowel disease
- Geographic risk factors such as liver fluke infections in Southeastern Asia
Modifiable risk factors (factors a person potentially could change or control) for HCC include:
- Chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection
- Excessive alcohol consumption
- Smoking
- Obesity, especially abdominal obesity
- Type 2 diabetes
- Consumption of a diet high in red meat, saturated fat, cholesterol, and sugar. It should be noted that a diet rich in n-3 polyunsaturated fatty acids, fish and poultry, vegetables, and fiber is inversely associated with HCC risk (decreases risk).
It's important to note that these risk factors are associated with the development of HCC in general, not specifically HCC Stage B. Having risk factors does not guarantee the development of HCC.
Lifestyle modifications, such as reducing alcohol intake and maintaining a healthy weight, may help reduce the risk of developing HCC. However, it's always recommended to consult with a healthcare professional for personalized advice and guidance.
To diagnose HCC Stage B, the following examinations, tests, and procedures are commonly performed:
- Medical history review: Your doctor will gather information about your previous medical conditions and symptoms.
- Physical examination: The doctor will conduct a physical exam to look for signs of HCC, such as pain or swelling in the abdomen.
- Blood tests: Several blood tests will be ordered to assess liver function, check for hepatitis B or C infection, and measure alpha-fetoprotein (AFP) levels.
- Imaging tests: Imaging techniques like ultrasound, CT scan, or MRI scan are used to check for the presence of tumors in the liver.
- Biopsy (if needed): In some cases, a biopsy may be ordered if there are atypical features observed in the imaging tests.
To determine the stage or severity of HCC Stage B, additional examinations, tests, and procedures may include:
- Staging evaluation: After an HCC diagnosis, staging is done to determine the extent of cancer. This includes assessing the size and number of tumors and checking if cancer has spread to nearby lymph nodes or distant tissues like bones or lungs.
- Immunohistochemistry: This test uses antibodies to identify specific markers in a tissue sample obtained during a biopsy. It helps in diagnosing and distinguishing different types of cancer.
It's important to consult with your healthcare provider for personalized advice on which examinations, tests, and procedures are suitable for your individual situation.
The goals of treatment for HCC Stage B are to achieve long-term cancer-free survival and to prevent postoperative liver failure. The recommended treatment options for Stage B HCC include:
- Surgical resection: This involves removing the tumor and surrounding tissue. The goal is to remove all malignant tissue while preserving enough healthy liver tissue to prevent liver failure.
- Liver transplantation: In this procedure, the diseased liver is replaced with a healthy liver from a donor. Liver transplantation can offer a long-term survival benefit, but the availability of suitable donors can be limited.
- Radiofrequency ablation (RFA): RFA uses heat to destroy cancer cells. It is considered a curative therapy for early-stage HCC and can be an alternative to surgery for patients who are not suitable candidates for resection or transplantation.
- Local ablation: This includes other techniques like microwave ablation or cryoablation, which also aim to destroy cancer cells using heat or extreme cold.
It is important to note that the choice of treatment depends on various factors, including the stage of the tumor, liver function, performance status, and patient-specific characteristics. Health behavior changes such as maintaining a healthy diet, exercising regularly, and avoiding alcohol can also support treatment outcomes.
Remember, treatment decisions should be made in consultation with a healthcare professional who can assess your specific situation.